# Adoptive Cell Therapy Following Non-myeloablate Chemotherapy in Metastatic Melanoma Patients

> **NCT00287131** · PHASE2 · UNKNOWN · sponsor: **Sheba Medical Center** · enrollment: 70 (estimated)

## Conditions studied

- Metastatic Melanoma

## Interventions

- **PROCEDURE:** Procedure - Adoptive cell transfer

## Key facts

- **NCT ID:** NCT00287131
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-01
- **Primary completion:** 2012-12
- **Final completion:** 2013-11
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2012-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00287131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00287131, "Adoptive Cell Therapy Following Non-myeloablate Chemotherapy in Metastatic Melanoma Patients". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00287131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*